IDEX Corporation (IEX) Sees New Investment From BlackRock Inc.
BlackRock Inc. has acquired a new stake in IDEX Corporation (NYSE:IEX), purchasing over 5.7 million shares valued at approximately $1.3 billion, representing 7.78% of the company. Other institutional investors also adjusted their positions in IEX. The article also covers recent analyst sentiment, including upward revisions to earnings forecasts by Zacks Research, a recent board resignation, and IDEX's financial performance and dividend announcement.
Will Strength in Engineered Fastening Unit Continue to Drive SWK's Growth?
Stanley Black & Decker (SWK) is experiencing solid growth in its Engineered Fastening segment, driven by strong performance in the automotive and industrial markets. The company completed a significant cost-reduction program in late 2025, generating substantial savings, and analysts are optimistic about its future profitability. SWK's valuation and Zacks Rank #2 (Buy) suggest continued positive momentum.
Zacks Research Issues Positive Outlook for IDEX Earnings
Zacks Research has issued a positive outlook for IDEX, increasing its earnings per share estimates for Q3 2026 and projecting higher EPS for FY2026, FY2027, and FY2028. The company recently surpassed analyst expectations for its last quarter, reporting $2.32 EPS against a $2.11 consensus and reaffirming its FY2026 EPS guidance. Analyst sentiment remains favorable, with a "Moderate Buy" consensus and an average price target above the current stock price.
IDEX Corporation stock holds firm as earnings beat supports 2026 outlook
IDEX Corporation's stock is holding firm in the mid-$230s, buoyed by a recent earnings beat and steady mid-single-digit revenue growth. Analysts maintain a "Moderate Buy" consensus with a price target of $260.80, suggesting potential upside for the diversified industrial company. The company's focus on highly engineered products and efficiency efforts are contributing to its strong financial performance.
Mitsubishi UFJ Asset Management Co. Ltd. Buys Shares of 180,901 IDEX Corporation $IEX
Mitsubishi UFJ Asset Management Co. Ltd. recently acquired 180,901 shares of IDEX Corporation, valued at approximately $41.1 million, giving it a 0.25% stake in the company. Institutional investors collectively own 97.96% of IDEX, which reported strong quarterly earnings and revenue growth. Analysts currently have a "Moderate Buy" consensus rating for IDEX, with an average price target of $260.80.
GE HealthCare appoints William Grogan as Chief Financial Officer
GE HealthCare has announced the appointment of William (Bill) Grogan as its new Chief Financial Officer, effective September 14, 2026. Grogan previously served as EVP and CFO at Xylem Inc., and prior to that, spent over a decade at IDEX Corporation. He is expected to lead GE HealthCare's financial strategy, focusing on growth, operational efficiency, and long-term value creation.
GE HealthCare appoints new CFO
GE HealthCare has appointed William (Bill) Grogan as its new chief financial officer, effective September 14, 2026. Grogan brings extensive financial leadership experience from Xylem Inc. and IDEX Corporation, where he significantly contributed to growth and financial performance. His appointment follows other recent leadership changes at GE HealthCare, as the company aims to simplify operations and accelerate its precision care strategy.
IDEX (NYSE:IEX) Board Shift Puts Valuation Back In Focus
IDEX (NYSE:IEX) is experiencing renewed market focus following a board change, prompting a re-evaluation of its long-term valuation. The company's cost discipline and specialized operations are viewed as supportive factors, while potential risks include tariffs and uneven industrial demand. The article emphasizes that sustained operational improvements, margin execution, and effective cost management will be crucial in shaping IDEX's future market direction and valuation outlook.
GE HealthCare Hires Bill Grogan as Finance Chief
GE HealthCare has appointed William (Bill) Grogan as its new chief financial officer, effective September 14, 2026. Grogan previously served as executive VP and CFO at Xylem Inc., and held finance leadership roles at IDEX Corp., Walgreens, Crane Co., and Sears Holdings Corp. He succeeds Jay Saccaro, who announced his departure last month.
Oxbow Advisors LLC Acquires Shares of 16,911 IDEX Corporation $IEX
Oxbow Advisors LLC recently acquired 16,911 shares of IDEX Corporation (NYSE:IEX), valued at approximately $3.84 million, contributing to institutional investors owning 97.96% of the company. IDEX maintains a "Moderate Buy" consensus rating from analysts, with a target price of $260.80, and reported strong Q2 earnings and revenue, alongside a quarterly dividend of $0.73 per share.
IDEX Announces Board Resignation and Governance Adjustment
IDEX Corporation announced that director L. Paris Watts-Stanfield resigned from its Board of Directors, effective immediately, with the company stating her departure was not due to any disagreement. Following her resignation, the Board reduced its size from ten to nine directors, an adjustment seen as a move to streamline board deliberations and signal governance stability. Analysts currently rate IEX stock as a Buy with a $280.00 price target, and TipRanks' AI Analyst considers it an "Outperform" due to strong fundamentals and a positive earnings update.
IDEX Corp. stock underperforms Tuesday when compared to competitors
Shares of IDEX Corp. (IEX) fell 2.59% on Tuesday to $234.16, underperforming the broader market as the S&P 500 Index and Dow Jones Industrial Average also declined. The stock closed 3.95% below its 52-week high.
GE HealthCare Appoints William Grogan as New CFO
GE HealthCare has appointed William K. Grogan as its new Chief Financial Officer, effective September 14, 2026. Grogan, bringing extensive financial leadership experience from Xylem Inc. and IDEX Corporation, will succeed interim CFO George A. Newcomb. His compensation package includes a significant base salary, bonus, and multi-year equity incentives, aiming to align his financial incentives with the company's long-term shareholder value and governance standards.
GE HealthCare Appoints William Grogan as CFO Sept. 14 | GEHC Stock News
GE HealthCare (Nasdaq: GEHC) has announced the appointment of William (Bill) Grogan as its new Chief Financial Officer, effective September 14, 2026. Grogan joins from Xylem Inc., where he served as CFO and was instrumental in integrating a $7.5 billion acquisition, driving significant margin expansion, and optimizing capital deployment. His previous experience also includes over a decade at IDEX Corporation, where he repositioned its portfolio towards higher-growth markets and contributed to a doubling of the company's market capitalization.
Nuance Investments LLC Buys New Shares in IDEX Corporation $IEX
Nuance Investments LLC has acquired 7,459 new shares in IDEX Corporation, valued at approximately $1.69 million, during the second quarter. This move is part of broader institutional interest, with collective ownership in IDEX reaching 97.96% of outstanding stock. The company recently reported strong quarterly earnings, exceeding analyst expectations, and maintains a "Moderate Buy" consensus among analysts with a positive price target.
GSA Capital Partners LLP Acquires Shares of 4,526 IDEX Corporation $IEX
GSA Capital Partners LLP recently acquired 4,526 shares of IDEX Corporation (NYSE:IEX), valued at approximately $1.03 million, as disclosed in their latest 13F filing. Other institutional investors like Primecap Management Co. CA and State Street Corp also significantly increased their holdings in IDEX. The company reported strong Q2 earnings, surpassing analyst estimates, and has an annualized dividend of $2.92.
IDEX Corporation stock holds above $240 as analysts maintain moderate buy view
IDEX Corporation (US45167R1041) stock is trading above $240 in mid-August 2026, with analysts projecting full-year 2026 EPS between $8.70 and $8.85 and an average 12-month price target of $260.80. The company recently reported Q2 EPS of $2.32, beating estimates, and quarterly revenue of $920.6 million, showing 6.4% year-over-year growth. The stock's performance reflects steady progress and institutional ownership, driven by its specialized industrial product offerings.
ETFs Investing in IDEX Corporation Stocks
This article lists numerous Exchange Traded Funds (ETFs) that hold IDEX Corporation stocks, providing investors with options for more accessible and lower-risk investment opportunities. Each ETF entry includes details such as market value, weight of IDEX stock, issuer, management style, focus, expense ratio, assets under management (AUM), price, change percentage, relative volume, and 3-year NAV total return. The ETFs span various categories including total market, large cap, small cap, thematic (e.g., water, infrastructure), and dividend-focused funds.
L. Paris Watts-Stanfield resigns from IDEX Board
L. Paris Watts-Stanfield has resigned from the IDEX Corp board of directors, effective August 13, 2026. This resignation reduced the board's size from ten to nine directors and was not due to any disagreement with the company's operations, policies, or practices. The change was reported in an SEC 8-K filing on August 17, 2026.
IDEX Corporation Announces Resignation of L. Paris Watts-Stanfield from Board of Directors, Effective August 13, 2026
IDEX Corporation announced the resignation of L. Paris Watts-Stanfield from its Board of Directors, effective August 13, 2026. Her resignation was not due to any disagreement with the company's operations, policies, or practices. Following her departure, the Board size was reduced from ten to nine directors.
IDEX Corporation (NYSE:IEX) Given Consensus Recommendation of "Moderate Buy" by Brokerages
IDEX Corporation (NYSE:IEX) has received a consensus "Moderate Buy" rating from brokerages, with an average 12-month price target of $260.80. The company recently surpassed quarterly earnings expectations, reporting $2.32 EPS against an estimated $2.11, and revenue of $920.6 million. IDEX also announced a quarterly dividend of $0.73 per share and has seen recent insider stock sales, with the CAO selling 385 shares.
IDEX (IEX) Rides A Strong Narrative, Is It Still Below Fair Value?
IDEX (IEX) has shown strong performance over the past year with a 47.17% total return, driven by solid revenue and net income. While its share price has risen significantly, analysts still consider it undervalued, with a fair value estimated at $254.50 compared to its last close of $238.94. The company's recent acquisition of Mott is expected to enhance capabilities and revenue, although potential risks like tariff pressures and softer demand in some sectors could challenge this bullish outlook.
Insider Selling: IDEX (NYSE:IEX) CAO Sells $91,857.15 in Stock
IDEX Chief Accounting Officer Lisa Anderson recently sold 385 shares of company stock, totaling $91,857.15, reducing her stake by 8.17%. Despite this insider sale, analysts generally maintain a "Moderate Buy" rating for IDEX with an average target price of $260.80, following strong Q2 earnings and a dividend announcement. The company, which specializes in engineered fluidics systems, recently traded at $239.25 and has a market capitalization of $17.64 billion.
Idex SVP Lisa Anderson sells $91,859 in company stock By Investing.com
Lisa Anderson, Senior Vice President at IDEX Corp. (NASDAQ:IEX), sold 385 shares of company stock for $91,859 on August 12, 2026, after acquiring the same number of shares through options exercise. Following the transactions, Anderson directly owns 4,327 shares. The sale occurred while IDEX stock is near its 52-week high, and InvestingPro analysis suggests it is overvalued, despite recent positive earnings and analyst upgrades.
Idex SVP Lisa Anderson sells $91,859 in company stock
Lisa Anderson, SVP at IDEX Corp., sold 385 shares for $91,859 on August 12, 2026, after acquiring the same number of shares through option exercise. This transaction occurred while IDEX stock is trading near its 52-week high and appears overvalued based on InvestingPro analysis. Despite the insider sale, recent news indicates positive developments for IDEX, including strong Q2 results, an upgraded rating from Mizuho, and an increased price target from Stifel, reflecting a positive trajectory for the company.
IDEX Corp (IEX) SVP Lisa Anderson exercises 385 options and sells matching shares
Lisa M. Anderson, SVP, GC, CAO & Corporate Secretary at IDEX Corp (IEX), exercised options for 385 shares at $93.27 each and subsequently sold all 385 shares at a weighted average price of $238.5949 per share. The options were originally granted in 2018 and set to expire in 2027. Following this exercise-and-sell transaction, Anderson's direct option holdings for this grant were reduced to zero, while her common stock holdings remain at 4,327 shares.
Pool Corporation (POOL) Stock Forecasts
Argus has lowered its target price for Pool Corporation (POOL) to $191.00, down from the current price of $200.57. Pool Corp, which distributes swimming pool supplies, was the subject of a report dated August 12, 2026. The report also notes a bullish technical assessment for the stock in the intermediate term.
IEX: Strong Buy Ratings And Ongoing Buybacks Will Support Future Returns
IDEX Corporation (IEX) has received strong buy ratings from analysts, with price targets around $280, indicating a potential upside of 15.20%. The company's fair value has been increased to $254.50, driven by updated assumptions for revenue growth and profit margins. IDEX has also been actively repurchasing shares, with 354,423 shares bought back for $75 million between April and June 2026.
Century Aluminum Q2 Earnings Lag Estimates, Sales Rise Y/Y
Century Aluminum (CENX) reported Q2 2026 earnings per share of $2.39, missing the Zacks Consensus Estimate but up significantly from a loss in the prior year. Net sales rose 19.7% year-over-year to $752.1 million, driven by higher metal prices and shipments, despite also missing estimates. The company forecasts Q3 2026 adjusted EBITDA between $325 million and $345 million.
Assenagon Asset Management S.A. Has $5.51 Million Stock Holdings in IDEX Corporation $IEX
Assenagon Asset Management S.A. significantly reduced its stake in IDEX Corporation, selling 81.9% of its holdings but still retaining shares valued at $5.51 million. Despite this reduction, institutional investors collectively own 97.96% of IDEX, and analysts maintain a "Moderate Buy" consensus rating with an average price target of $260.80. IDEX reported strong quarterly earnings, beating estimates, and offers a quarterly dividend of $0.73.
IDEX CORP /DE/ SEC Filing (Aug 12, 2026)
This article details an SEC Form 144 filing by IDEX Corp /DE/ (IEX) on August 12, 2026. The filing indicates a proposed sale of 385 common shares with an aggregate market value of $91831.96, acquired through a stock option release on the same date. The transaction is categorized as neutral in sentiment and impact according to AI analysis.
IDEX Corp. stock outperforms competitors on strong trading day
IDEX Corp. (IEX) saw its stock rise by 1.35% to $240.52 on Wednesday, outperforming the S&P 500 Index and the Dow Jones Industrial Average on a mixed trading day. This marks the second consecutive day of gains for the company's stock.
Middleby's Q2 Earnings Beat Estimates on Commercial Foodservice Strength
The Middleby Corporation (MIDD) reported strong second-quarter 2026 results, surpassing earnings and revenue estimates driven by robust performance in its Commercial Foodservice segment. The company saw significant growth in U.S. dealer demand and replacement activity, along with increased international sales. Despite some margin pressures from tariffs and inflation, Middleby generated higher free cash flow and raised its full-year 2026 outlook.
This Intuitive Surgical Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday
Several top Wall Street analysts have updated their ratings for key companies. Mizuho upgraded IDEX Corp to Outperform, Deutsche Bank upgraded Entegris Inc to Buy, Oppenheimer upgraded Intuitive Surgical Inc to Outperform, and Citizens upgraded Okta Inc to Market Outperform, all with increased price targets.
Mizuho upgrades IDEX stock rating on portfolio shift, raises PT to $280
Mizuho has upgraded IDEX Corp (NYSE:IEX) to Outperform from Neutral and raised its price target to $280, citing the company's successful portfolio repositioning towards higher-growth, less-cyclical markets. This shift is leading to stronger organic growth and improved revenue visibility, with orders accelerating significantly in Q2 2026. Stifel also recently raised its price target for IDEX to $268, maintaining a Buy rating due to strong Q2 earnings and increased full-year guidance.
Mizuho upgrades IDEX stock rating on portfolio shift, raises PT to $280
Mizuho upgraded IDEX Corp (NYSE:IEX) to Outperform from Neutral and increased its price target to $280 from $210, citing the company's successful portfolio repositioning towards higher-growth, less-cyclical markets. This shift is leading to stronger organic growth and improved revenue visibility, with second-quarter 2026 organic total orders up 28%. Mizuho also raised its 2026 and 2027 adjusted earnings per share estimates for IDEX.
IDEX Corp. stock outperforms competitors on strong trading day
IDEX Corp. (IEX) saw its stock rally 1.73% to $237.31 on a tough trading day for the broader market, outperforming the S&P 500 and Dow Jones Industrial Average, which both fell. The company's stock closed 2.66% below its 52-week high reached on July 29th. This strong performance occurred despite a general market downturn.
Contravisory Investment Management Inc. Purchases Shares of 5,194 IDEX Corporation $IEX
Contravisory Investment Management Inc. recently acquired 5,194 shares of IDEX Corporation (NYSE: IEX) during the second quarter, valued at approximately $1.18 million. IDEX exceeded quarterly earnings expectations with $2.32 EPS and $920.6 million in revenue, leading analysts to maintain a "Moderate Buy" rating and an average price target of $258.67. The company also announced a quarterly dividend of $0.73 per share, representing a 1.2% yield.
International Flavors & Fragran (IFF) Stock Forecasts
This article provides a stock forecast for International Flavors & Fragrances (IFF), noting that shares rose due to increased guidance. It highlights IFF as the largest specialty ingredients producer globally, selling ingredients for various industries. The report, dated August 5, 2026, also mentions the company's proprietary formulations and partnerships with customers.
AptarGroup, Inc. (ATR) Stock Forecasts
Argus has lowered its target price for AptarGroup, Inc. (ATR) to $150.00 from its current price of $135.42. AptarGroup, headquartered in Crystal Lake, Illinois, is a leading global supplier of dispensing systems for consumer goods and pharmaceutical markets. The report was published on August 05, 2026, by Argus.
Pentair plc (PNR) stock price, news, quote and history
This article provides a comprehensive overview of Pentair plc (PNR) stock, including its current price, key statistics, historical data, and financial performance. It details the company's operations across three segments: Flow, Water Solutions, and Pool, outlining the products and brands within each. The information is supplemented with analyst insights, earnings trends, and a comparison with similar companies in the Specialty Industrial Machinery industry.
DA Davidson Adjusts Price Target on IDEX to $240 From $230
DA Davidson has adjusted its price target on IDEX (IEX) to $240 from $230. The company currently holds an average analyst rating of overweight, with a mean price target across analysts of $250.92.
Carlisle Companies Incorporated (CSL) Stock Forecasts
Carlisle Companies Inc. (CSL) is a holding company specializing in single-ply roofing products and systems for commercial buildings. Argus has raised its target price for CSL to $406.00, from a current price of $387.49, indicating a positive outlook for the industrial sector company.
Royal Bank of Canada Decreases Position in IDEX Corporation $IEX
Royal Bank of Canada reduced its stake in IDEX Corporation by 6.9% in the first quarter of 2026, selling 6,645 shares and retaining 89,664 shares valued at $17 million. Despite this reduction, institutional investors collectively own 97.96% of IDEX. The company reported strong quarterly results, exceeding analyst expectations for both earnings and revenue, and analysts maintain a "Moderate Buy" consensus with an average price target above the current share price.
Rollins, Inc. (ROL) Stock forecasts
Argus has lowered its rating for Rollins, Inc. (ROL) to HOLD, as reported on August 5, 2026. Rollins Inc. specializes in pest and wildlife control services, along with protection against termite damage, rodents, and insects, serving both commercial and residential clients in over 70 countries through its subsidiaries and independent franchises. The current stock price for ROL is $37.41.
The Middleby Corporation (MIDD) Stock Forecasts
Argus has raised its target price for The Middleby Corporation (MIDD) to $146.00, with the current price standing at $134.59. Middleby Corp specializes in designing, manufacturing, and distributing foodservice equipment for commercial restaurants and institutional kitchens. The report, dated August 5, 2026, highlights the company's broad line of equipment used for food preparation, cooking, baking, chilling, and packaging.
D.A. Davidson Maintains IDEX Corp(IEX.US) With Hold Rating, Raises Target Price to $240
D.A. Davidson has reiterated a Hold rating on IDEX Corp (IEX.US) while increasing its price target to $240. This adjustment reflects the firm's updated valuation for the company.
IDEX Corp. stock underperforms Thursday when compared to competitors
IDEX Corp. (IEX) stock fell 1.38% on Thursday, closing at $233.71, underperforming the broader market. This marked the second consecutive day of losses for the company, as the S&P 500 Index (SPX) also declined by 0.18% and the Dow Jones Industrial Average (DJIA) fell by 0.85%.
IDEX CORPORATION : ARGUS RESEARCH RAISES TARGET PRICE TO $260 FROM $250
Argus Research has increased its target price for IDEX Corporation (IEX.N) to $260 from $250. This change reflects a revised outlook from the research firm regarding the company's valuation. The article is a brief news alert from Reuters.
IDEX CORPORATION : ARGUS RESEARCH RAISES TARGET PRICE TO $260 FROM $250
Argus Research has increased its target price for IDEX Corporation (IEX.N) to $260 from $250. This update was reported by Reuters on August 6, 2026. The article itself is a brief news alert, providing no further details on the rationale behind the target price adjustment.
